$微创医疗(0085_老虎社区_美港股上老虎

$微创医疗(00853)$ 老实说，心通和CRM合并，直接把微创旗下最关键的两块业务绑定在一起，升级成了覆盖全流程的“大心脏病平台”，市场以前没给溢价，现在清晰了，作为母公司理应获得价值重估

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":511045614879672,"tweetId":"511045614879672","gmtCreate":1765779933547,"gmtModify":1765779935695,"author":{"id":4130491681502130,"idStr":"4130491681502130","authorId":4130491681502130,"authorIdStr":"4130491681502130","name":"智慧与勇气","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><a href=\"https://laohu8.com/S/00853\">$微创医疗(00853)$</a> 老实说，心通和CRM合并，直接把微创旗下最关键的两块业务绑定在一起，升级成了覆盖全流程的“大心脏病平台”，市场以前没给溢价，现在清晰了，作为母公司理应获得价值重估</body></html>","htmlText":"<html><head></head><body><a href=\"https://laohu8.com/S/00853\">$微创医疗(00853)$</a> 老实说，心通和CRM合并，直接把微创旗下最关键的两块业务绑定在一起，升级成了覆盖全流程的“大心脏病平台”，市场以前没给溢价，现在清晰了，作为母公司理应获得价值重估</body></html>","text":"$微创医疗(00853)$ 老实说，心通和CRM合并，直接把微创旗下最关键的两块业务绑定在一起，升级成了覆盖全流程的“大心脏病平台”，市场以前没给溢价，现在清晰了，作为母公司理应获得价值重估","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/511045614879672","repostId":0,"isVote":1,"tweetType":1,"viewCount":277,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["00853"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":168,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}